Lataa...
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
Liraglutide is a glucagon-like peptide-1 analog with pharmacokinetic properties suitable for once-daily administration approved by the Food and Drug Administration for the treatment of patients with type 2 diabetes. Clinical trial data from large, controlled studies demonstrate the safety and effica...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047975/ https://ncbi.nlm.nih.gov/pubmed/21437090 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|